PitchSend

Investor Presentaiton

8 We Value Our R&D ■R&D investments remain stable R&D Investment (mn $NT) ■Strong focus on R&D with +125 experts (Ph.D:27) -R&D (% TO sales) 330 10% 9% 9% 320 R&D Staffs 8% 8% Employees 310 7% 7% 300 6% 290 16% 280 84% 5% 4% 3% 270 2% 260 1% 250 0% 2015 2016 2017 ScinoPharm

View entire presentation